As a type of chemotherapy drug, mitomycin (Mutamycin®) is prescribed to treat stomach or pancreatic cancer in adults. It is approved for use when the cancer has not adequately responded to previous treatment. The medicine comes as an injection that is given into a vein once every six to eight weeks.
Mitomycin belongs to a group of medications known as antineoplastic antibiotics. The active ingredient in the drug is sometimes referred to as mitomycin-C, or simply MTC. It works by interfering with cell division, which helps prevent cancer cells from growing and multiplying.
(Click Mitomycin for a closer look at this chemotherapy drug, including an explanation of how the drug works, possible side effects, dosing instructions, and more.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Mutamycin. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2012. Available from Wolters Kluwer Health, Inc. Accessed November 3, 2012.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed November 3, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click